Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

71.07
Delayed Data
As of May 25
 +1.31 / +1.88%
Today’s Change
51.05
Today|||52-Week Range
135.59
+21.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-283.2M-226.4M-412.8M-360.4M
 
 
 
 
 
Depreciation442.8K1.7M3.8M4.6M
 
 
 
 
 
Total Other Cash Flow194.3M40.5M58.1M75.7M
 
 
 
 
 
Funds From Operations-88.4M-184.2M-350.9M-280.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-699.0K-21.3M-8.4M-14.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-87.7M-162.9M-342.4M-265.4M
 
 
 
 
 
 
InvestingIncrease In Investments-204.3M-640.7M-511.5M-231.1M
 
 
 
 
 
Decrease In Investments112.4M257.2M456.5M529.3M
 
 
 
 
 
Capital Expenditures-4.6M-5.9M-5.1M-10.4M
 
 
 
 
 
Net Cash Flow Investing-96.6M-389.5M-60.1M287.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00--0.00--
Long Term Borrowings0.000.00447.6M0.00
 
 
Long Term Debt Reduction0.000.00--0.00--
Net Proceeds Stock Sale191.0M565.5M5.2M2.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.000.00--0.00--
Other Uses - Financing0.000.0038.4M0.00
 
 
Net Cash Flow - Financing191.0M565.5M414.4M2.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00-376.0K-873.0K1.1M
 
 
 
 
 
Net Change In Cash6.7M13.1M11.8M25.2M